Co-administration of Favipiravir and the Remdesivir Metabolite GS-441524 Effectively Reduces SARS-CoV-2 Replication in the Lungs of the Syrian Hamster Model - Chiba, Shiho; Kiso, Maki; Nakajima, Noriko; Iida, Shun; Maemura, Tadashi; Kuroda, Makoto; Sato, Yuko; Ito, Mutsumi; Okuda, Moe; Yamada, Shinya; Iwatsuki-Horimoto, Kiyoko; Watanabe, Tokiko; et al. (mBio, 2022)
Keywords: Animals; Antiviral Agents - pharmacology; COVID-19; COVID-19 Drug Treatment; Cricetinae; favipiravir; GS-441524; Lung; Mesocricetus; remdesivir; Research Article; SARS-CoV-2; Syrian hamster; Virology; Syrian hamster; SARS-CoV-2; GS-441524; remdesivir; favipiravir